ABT vs MDT
ABT and MDT side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ABTABBOTT LABORATORIES | MDTMedtronic plc |
|---|---|---|
| Market cap | $178.31B | $118.48B |
| P/E (TTM) | 28.7 | 22.8 |
| P/B | 3.43 | 2.36 |
| P/S | 4.0x | 3.3x |
| Dividend yield | 2.31% | 3.07% |
| Revenue | $45.13B(TTM) | $37.54B(TTM) |
| Revenue growth (YoY) | 5.7% | 8.4% |
| Net income | $6.28B(TTM) | $430.00M(TTM) |
| Earnings growth (YoY) | -51.3% | 3.0% |
| EPS, diluted | $3.57(TTM) | $4.06(TTM) |
| EBIT margin | 18.2% | 17.8% |
| ROE | 12.5% | 0.0% |
| ROIC | 8.3% | 7.0% |
| Piotroski F | — | 8/9 |
| 1y total return | -21.1% | +1.3% |
Figures from SEC filings · for reference only · not investment advice
$10,000 투자 성장: ABT vs MDT
| 지표 | ABT | MDT |
|---|---|---|
| 최종 가치 | $33.1K | $14.7K |
| 총수익률 | +230.6% | +46.8% |
| CAGR | +12.3% | +3.8% |
| 변동성 | 23.9% | 23.3% |
| 샤프 | 0.43 | 0.10 |
| 소르티노 | 0.62 | 0.14 |
| 최대 낙폭 | -39.6% | -45.3% |
공통 거래일 2600일 기준, 2016-05-13 → 2026-09-16 · 무위험수익률 4.14% (현재 단기 국채 금리, 고정 적용)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)